Payment overview · 2025
General Payments
$16.13
1 reported records · 1 companies
Healthcare provider profile · identity verified
Binitha Joseph, M.D
Allopathic & Osteopathic Physicians|Internal Medicine · OAKDALE, LA · NPI 1881893139
Verified facts
What the public records show
CMS Open Payments records show Binitha Joseph, M.D received $16.13 in general payments during 2025 across 1 reported records.
Paratek Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.13 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.13 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $16.13 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 463 | 103 |
| Gabapentin | Gabapentin | 417 | 77 |
| Amlodipine Besylate | Amlodipine Besylate | 336 | 90 |
| Levothyroxine Sodium | Levothyroxine Sodium | 335 | 67 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 329 | 87 |
| Furosemide | Furosemide | 275 | 71 |
| Omeprazole | Omeprazole | 258 | 53 |
| Eliquis | Apixaban | 220 | 31 |
| Carvedilol | Carvedilol | 213 | 43 |
| Losartan Potassium | Losartan Potassium | 210 | 56 |
| Lisinopril | Lisinopril | 206 | 46 |
| Duloxetine Hcl | Duloxetine Hcl | 205 | 43 |
| Metformin Hcl | Metformin Hcl | 182 | 41 |
| Pantoprazole Sodium | Pantoprazole Sodium | 180 | 54 |
| Montelukast Sodium | Montelukast Sodium | 170 | 44 |
| Potassium Chloride | Potassium Chloride | 159 | 33 |
| Metoprolol Succinate | Metoprolol Succinate | 151 | 33 |
| Ozempic | Semaglutide | 147 | 32 |
| Sertraline Hcl | Sertraline Hcl | 147 | 33 |
| Farxiga | Dapagliflozin Propanediol | 140 | 23 |
| Metoprolol Tartrate | Metoprolol Tartrate | 140 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 138 | 24 |
| Jardiance | Empagliflozin | 137 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 126 | 31 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 123 | 39 |
| Clopidogrel | Clopidogrel Bisulfate | 120 | 39 |
| Tramadol Hcl | Tramadol Hcl | 119 | 23 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 115 | 26 |
| Tradjenta | Linagliptin | 114 | 16 |
| Glipizide Er | Glipizide | 108 | 27 |
| Alprazolam | Alprazolam | 95 | 17 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 87 | 41 |
| Famotidine | Famotidine | 86 | 16 |
| Pravastatin Sodium | Pravastatin Sodium | 86 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 86 | 12 |
| Metformin Hcl Er | Metformin Hcl | 85 | 20 |
| Clonidine Hcl | Clonidine Hcl | 83 | 22 |
| Torsemide | Torsemide | 83 | 26 |
| Levetiracetam | Levetiracetam | 82 | 16 |
| Ezetimibe | Ezetimibe | 78 | 14 |
| Allopurinol | Allopurinol | 76 | 21 |
| Donepezil Hcl | Donepezil Hcl | 76 | 16 |
| Mirtazapine | Mirtazapine | 73 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 72 | 23 |
| Trazodone Hcl | Trazodone Hcl | 72 | 21 |
| Hydrochlorothiazide | Hydrochlorothiazide | 70 | 15 |
| Entresto | Sacubitril/Valsartan | 65 | 12 |
| Spironolactone | Spironolactone | 62 | 19 |
| Alendronate Sodium | Alendronate Sodium | 60 | 15 |
| Pregabalin | Pregabalin | 59 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 58 | 26 |
| Hydralazine Hcl | Hydralazine Hcl | 57 | 13 |
| Prednisone | Prednisone | 56 | 40 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 53 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 51 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | 12 |
| Amitriptyline Hcl | Amitriptyline Hcl | 46 | suppressed |
| Simvastatin | Simvastatin | 46 | suppressed |
| Aripiprazole | Aripiprazole | 43 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | 13 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 42 | 13 |
| Meclizine Hcl | Meclizine Hcl | 40 | suppressed |
| Novolog | Insulin Aspart | 40 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 40 | suppressed |
| Cefdinir | Cefdinir | 39 | 39 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 38 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 37 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Meloxicam | Meloxicam | 37 | 18 |
| Rybelsus | Semaglutide | 37 | suppressed |
| Glimepiride | Glimepiride | 36 | suppressed |
| Humalog | Insulin Lispro | 36 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Digoxin | Digoxin | 33 | suppressed |
| Levofloxacin | Levofloxacin | 32 | 32 |
| Olanzapine | Olanzapine | 32 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 32 | suppressed |
| Trulicity | Dulaglutide | 32 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 31 | suppressed |
| Linzess | Linaclotide | 31 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | suppressed |
| Nifedipine Er | Nifedipine | 30 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 30 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 30 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 30 | suppressed |
| Xarelto | Rivaroxaban | 30 | 11 |
| Baclofen | Baclofen | 29 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 28 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Rivastigmine | Rivastigmine | 27 | suppressed |
| Sucralfate | Sucralfate | 27 | suppressed |
| Finasteride | Finasteride | 26 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 26 | suppressed |
| Valsartan | Valsartan | 26 | suppressed |
| Januvia | Sitagliptin Phosphate | 25 | suppressed |
| Ramipril | Ramipril | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | 14 |
| Divalproex Sodium | Divalproex Sodium | 24 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 24 | suppressed |
| Humalog Mix 50-50 Kwikpen | Insulin Lispro Protamin/Lispro | 23 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 23 | suppressed |
| Indapamide | Indapamide | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 23 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 15 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 21 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 21 | suppressed |
| Estradiol | Estradiol | 20 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Lovastatin | Lovastatin | 18 | suppressed |
| Mounjaro | Tirzepatide | 18 | suppressed |
| Novolin R | Insulin Regular, Human | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 17 | 15 |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 15 |
| Dutasteride | Dutasteride | 16 | suppressed |
| Fenofibrate | Fenofibrate | 16 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 12 |
| Novolin N | Insulin Nph Human Isophane | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | 15 |
| Oxycodone Hcl | Oxycodone Hcl | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 15 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 15 | suppressed |
| Tresiba | Insulin Degludec | 15 | suppressed |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Calcitriol | Calcitriol | 14 | suppressed |
| Cephalexin | Cephalexin | 14 | suppressed |
| Clonazepam | Clonazepam | 14 | suppressed |
| Ranolazine Er | Ranolazine | 14 | suppressed |
| Risperidone | Risperidone | 14 | suppressed |
| Roflumilast | Roflumilast | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | 13 |
| Celecoxib | Celecoxib | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Latanoprost | Latanoprost | 13 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Phenobarbital | Phenobarbital | 13 | suppressed |
| Synthroid | Levothyroxine Sodium | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Bumetanide | Bumetanide | 12 | suppressed |
| Dipyridamole | Dipyridamole | 12 | suppressed |
| Fluconazole | Fluconazole | 12 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 11 | suppressed |
| Rexulti | Brexpiprazole | 11 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.13 · 1 records | Paratek Pharmaceuticals, Inc. | NUZYRA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error